These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 22682513

  • 21. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
    Jeng JE, Wu HF, Tsai MF, Tsai HR, Chuang LY, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY, Tsai JF.
    Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
    [Abstract] [Full Text] [Related]

  • 22. The relationship between TNF alpha gene polymorphisms (-238/-308), TNF RII VNTR (p75) and outcomes of hepatitis B virus infection in Tunisian population.
    Sghaier I, Zidi S, Mouelhi L, Dabbech R, Ghazouani E, Brochot E, Stayoussef M, Yacoubi-Loueslati B.
    Gene; 2015 Sep 01; 568(2):140-5. PubMed ID: 25982858
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene.
    Ho SY, Wang YJ, Chen HL, Chen CH, Chang CJ, Wang PJ, Chen HH, Guo HR.
    Cancer Causes Control; 2004 Sep 01; 15(7):657-63. PubMed ID: 15280623
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F, Vangieri B, Cecere A, Gattoni A.
    Clin Ter; 2004 May 01; 155(5):187-99. PubMed ID: 15344567
    [Abstract] [Full Text] [Related]

  • 28. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.
    Sonzogni L, Silvestri L, De Silvestri A, Gritti C, Foti L, Zavaglia C, Bottelli R, Mondelli MU, Civardi E, Silini EM.
    Hepatology; 2002 Jul 01; 36(1):195-201. PubMed ID: 12085365
    [Abstract] [Full Text] [Related]

  • 29. Effect of IL-12B, IL-2, TGF-β1, and IL-4 polymorphism and expression on hepatitis B progression.
    Saxena R, Chawla YK, Verma I, Kaur J.
    J Interferon Cytokine Res; 2014 Feb 01; 34(2):117-28. PubMed ID: 24161121
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
    Dong ZZ, Yao DF, Yao M, Qiu LW, Zong L, Wu W, Wu XH, Yao DB, Meng XY.
    Hepatobiliary Pancreat Dis Int; 2008 Jun 01; 7(3):288-95. PubMed ID: 18522884
    [Abstract] [Full Text] [Related]

  • 36. Ethnic differences in polymorphisms of tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in patients with chronic hepatitis C virus infection.
    Zein NN, Germer JJ, El-Zayadi AR, Vidigal PG.
    Am J Trop Med Hyg; 2004 Apr 01; 70(4):434-7. PubMed ID: 15100460
    [Abstract] [Full Text] [Related]

  • 37. Transforming growth factor-β1 gene expression in hepatocellular carcinoma: a preliminary report.
    Farid IM, Hamza IM, El-Abd DM, Mohyi AM, AbdulLatif MM, Aref AT, Hamza DM.
    Arab J Gastroenterol; 2014 Apr 01; 15(3-4):142-7. PubMed ID: 25475758
    [Abstract] [Full Text] [Related]

  • 38. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
    Falleti E, Fabris C, Cmet S, Cussigh A, Bitetto D, Fontanini E, Fornasiere E, Bignulin S, Fumolo E, Bignulin E, Pirisi M, Toniutto P.
    Liver Int; 2011 Sep 01; 31(8):1137-43. PubMed ID: 21745286
    [Abstract] [Full Text] [Related]

  • 39. TGF-beta1 and C-erb-B2 neu oncoprotein in Egyptian HCV related chronic liver disease and hepatocellular carcinoma patients.
    El Bassuoni MA, Talaat RM, Ibrahim AA, Shaker OT.
    Egypt J Immunol; 2008 Sep 01; 15(1):39-50. PubMed ID: 20306668
    [Abstract] [Full Text] [Related]

  • 40. TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis.
    Nomair AM, Kandil LS, Nomeir HM, Kandil NS.
    Asian Pac J Cancer Prev; 2021 Oct 01; 22(10):3317-3326. PubMed ID: 34711009
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.